Alvitrox TZ 250mg/31.25mg Injection
Marketer
Alarius Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Alvitrox TZ 250mg/31.25mg Injection
Combiflox TZ, a 250mg/31.25mg injectable combination drug, combats various bacterial infections by inhibiting microbial growth and spread. Administration must be overseen by a medical professional; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and indigestion; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Disclose all current medications to your physician prior to use. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order lab tests and diagnostic imaging to monitor treatment response.
Uses of Alvitrox TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Alvitrox TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Alvitrox TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Alvitrox TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Alvitrox TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Alvitrox TZ 250mg/31.25mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. The beta-lactamase inhibitor, Tazobactum, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Alvitrox TZ 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Alvitrox TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Alvitrox TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Alvitrox TZ 250mg/31.25mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Alvitrox TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Alvitrox TZ 250mg/31.25mg Injection to individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Altering the dosage of Alvitrox TZ 250mg/31.25mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Alvitrox TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Alvitrox TZ 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Alvitrox TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Addiction potential | None. |
| Medication Classification | Antimicrobial Agents |
3,018 People bought this recently